In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Symphony finances development of three Lexicon candidates; Lexicon later reacquires development rights

Executive Summary

Lexicon Pharmaceuticals and private equity company Symphony Capital have formed Symphony Icon, a financing vehicle, with $45mm to fund development of Lexicon's three most advanced candidates over a four-year period.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Includes Contract
    • Private Placement
    • Special-Purpose Financing Vehicle

Related Companies

Advertisement
UsernamePublicRestriction

Register